Brief: Cstone Pharmaceuticals Loss For Year Was RMB902.7 Million
15/03/2023 13:41
March 15 (Reuters) - CStone Pharmaceuticals 2616.HK :
* LOSS FOR YEAR WAS RMB902.7 MILLION VERSUS RMB1,920.1
MILLION
* FY REVENUE RMB481.4 MILLION VERSUS RMB243.7 MILLION
* WORKING TO BRING NUMBER OF CLINICAL AND COMMERCIAL
DEVELOPMENTS
THAT WILL BE CATALYSTS FOR GROWTH FOR REST OF 2023
Source text for Eikon: ID:nHKS8zTLl5
Further company coverage: 2616.HK
Recent news on CStone Pharmaceuticals
See all newsBrief: CStone Pharmaceuticals Says CEO Purchases 496,000 Shares For Over HK$2.7 Million From Sept 17-22
Brief: CStone Pharmaceuticals Posts HY Loss Of Rmb252.3 Million
China's CStone Pharmaceuticals H1 revenue soars on drug sales
Brief: Cstone Pharmaceuticals Receives NMPA IND Approval For CS5007 In China
Brief: CStone Pharmaceuticals Says Directors And Senior Management Purchase 2.4 Million Shares In June 2026